Medtronic PLC (MDT)
Cash ratio
Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 2,218,000 | 1,284,000 | 1,284,000 | 1,543,000 | 1,543,000 |
Short-term investments | US$ in thousands | 6,747,000 | 6,721,000 | 6,721,000 | 6,416,000 | 6,416,000 |
Total current liabilities | US$ in thousands | 12,879,000 | 10,789,000 | 10,789,000 | 9,051,000 | 9,051,000 |
Cash ratio | 0.70 | 0.74 | 0.74 | 0.88 | 0.88 |
April 30, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($2,218,000K
+ $6,747,000K)
÷ $12,879,000K
= 0.70
The cash ratio for Medtronic PLC has shown a gradual decrease over the years from 0.88 in April 2023 to 0.70 in April 2025. This indicates that the company's ability to cover its short-term liabilities with its available cash and cash equivalents has slightly weakened. While a cash ratio above 1.0 is generally considered healthy, the company's ratios fall below this threshold, suggesting a potential liquidity concern. It would be prudent for Medtronic PLC to closely monitor its liquidity position to ensure it can meet its short-term obligations effectively.
Peer comparison
Apr 30, 2025